Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...
Essential tremor (ET) is a brain condition that causes uncontrollable shaking of the hands, head, and voice. In some cases, it can also cause your legs and trunk to shake. Also called benign essential ...
Praxis Precision Medicines’ commitment to forging ahead with ulixacaltamide in essential tremor (ET) has paid off. After brushing off a recommendation to end a phase 3 study earlier this year based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results